Immediate Impact

2 by Nobel laureates 26 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
Natural killer cell therapies
2024 StandoutNature
2 intermediate papers

Works of Christopher R. Cabanski being referenced

Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients
2019
Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Christopher R. Cabanski 616 476 271 332 28 1.1k
Yari Ciani 918 474 389 209 27 1.3k
Garrett M. Dancik 631 235 287 213 38 1.1k
Mariam Jamal‐Hanjani 427 403 459 375 38 1.1k
Guichao Li 602 443 409 208 44 1.2k
Stephanie M. McGregor 470 235 330 364 52 1.2k
Hossein Saboorian 301 365 445 381 24 1.1k
Manal Gabril 677 498 196 332 47 1.1k
Donavan T. Cheng 419 335 288 286 27 1.2k
Zheng Lv 611 490 515 205 31 1.2k
Antony C. P. Riddick 513 346 256 465 45 1.1k

All Works

Loading papers...

Rankless by CCL
2026